Firdapse — Medica
Lambert-Eaton myasthenic syndrome (LEMS)
Preferred products
- Ruzurgi
Initial criteria
- Patient meets the standard Amifampridine Prior Authorization Policy criteria
- Patient has tried the Preferred Product (Ruzurgi)
- Patient has demonstrated inadequate efficacy or unacceptable safety or tolerability to Ruzurgi, according to the prescriber
Approval duration
1 year